- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04001660
Subbrow Blepharoplasty Combined With Double Eyelid Surgery for Upper Eyelid Rejuvenation in Asian Women
June 26, 2019 updated by: Xijing Hospital
Subbrow blepharoplasty combined with double eyelid surgery excising the subbrow skin and the supratarsal upper eyelid skin, lifting and fixing the OOM flap, meanwhile restoring the natural and symmetrical appearance, is a safe, effective, and durable way for treating patients presenting with dermatochalasis.
Study Overview
Status
Unknown
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
30
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Shan XI
-
Xi'an, Shan XI, China, 710032
- Baoqiang Song
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
35 years to 65 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Visual, lacrimal gland and eyelid functions were normal The eyes and eyebrows are aged between 35 and 65 years Informed consent was signed and approved by ethics review
Exclusion Criteria:
- Congenital craniofacial deformity, acquired craniofacial injury Scar constitution, pregnancy Mental illness
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Subbrow Blepharoplasty Combined with Double Eyelid Surgery
An upper incision is made along the inferior margin of the eyebrow.
A lower incision is determined according to necessary amount of skin excision.
Then the skin and subcutaneous tissue were excised.
The orbicularis oculi muscle (OOM) was separated and an OOM flap dissection was extended to the width of 15mm.
A dissected OOM flap was lifted up and three transverse 3-0 nylon sutures were placed to fix it to the periosteum and then covered by the upper myocutaneous flap of the supraorbital rim.
Through eyelid-crease approach the supratarsal upper eyelid skin and orbital fat was excised, adjusted and reshaped double-fold eyelids at the same time.
|
An upper incision is made along the inferior margin of the eyebrow.
A lower incision is determined according to necessary amount of skin excision.
Then the skin and subcutaneous tissue were excised.
The orbicularis oculi muscle (OOM) was separated and an OOM flap dissection was extended to the width of 15mm.
A dissected OOM flap was lifted up and three transverse 3-0 nylon sutures were placed to fix it to the periosteum and then covered by the upper myocutaneous flap of the supraorbital rim.
Through eyelid-crease approach the supratarsal upper eyelid skin and orbital fat was excised, adjusted and reshaped double-fold eyelids at the same time.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
visual analog scale (VAS) scores
Time Frame: postoperative 6month
|
1, poor; 2, fair; 3, good; 4, very good; and 5, excellent
|
postoperative 6month
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
September 1, 2017
Primary Completion (ACTUAL)
March 1, 2018
Study Completion (ANTICIPATED)
December 31, 2019
Study Registration Dates
First Submitted
June 24, 2019
First Submitted That Met QC Criteria
June 26, 2019
First Posted (ACTUAL)
June 28, 2019
Study Record Updates
Last Update Posted (ACTUAL)
June 28, 2019
Last Update Submitted That Met QC Criteria
June 26, 2019
Last Verified
January 1, 2019
More Information
Terms related to this study
Other Study ID Numbers
- KY20192048-F-2
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Subbrow Blepharoplasty Combined with Double Eyelid Surgery
-
Mersin Training and Research HospitalEnrolling by invitation
-
Diablo Eye AssociatesAlcon ResearchTerminatedOpen Angle GlaucomaUnited States
-
Peking Union Medical CollegeRecruitingHidradenitis Suppurativa (HS) | Secukinumab | Hidradenitis Suppurativa (Acne Inversa)China
-
Rennes University HospitalCenter Eugene MarquisCompletedProstate Cancer | Prostate AdenocarcinomaFrance
-
Fifth Affiliated Hospital, Sun Yat-Sen UniversityThe First Affiliated Hospital of Nanchang University; West China Hospital; Hubei... and other collaboratorsNot yet recruiting
-
Shenzhen SiBiono GeneTech Co.,LtdUnknownNon-small Cell Lung CancerChina
-
Al-Azhar UniversityRecruitingKidney Stone | Retrograde Intrarenal Surgery | Ureteral StentEgypt
-
Xijing HospitalShaanxi Provincial People's Hospital; Tang-Du HospitalRecruiting
-
Henan Cancer HospitalWithdrawnStage IV Breast CancerChina
-
Medical University of BialystokCompletedOcular Hypertension | Glaucoma | Filtering Surgery